---
schema_version: "secwatch.filing_event.v1"
accession: "0001217234-24-000062"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T04:59:01.671946+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CareDx Q1 revenue $72M (-7% YoY); raises FY2024 revenue guidance to $274-282M

## Summary
- Revenue $72.0M, down 7% YoY from $77.3M but up 10% sequentially from Q4 2023.
- Net loss $16.7M ($0.32 loss per share) improved from $23.7M loss ($0.44) a year ago.
- Testing Services revenue $53.8M, down 13% YoY but up 15% sequentially; patient results ~42,000, up 6% sequentially.
- Adjusted EBITDA loss $1.9M vs $6.4M loss in Q1 2023 and $10.3M loss in Q4 2023.
- Raises FY2024 revenue guidance to $274-282M; cash $216M with no debt.

## SEC filing metadata
- accession: 0001217234-24-000062
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/0001217234-24-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/cdna-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001217234-24-000062
- JSON: https://secwatch.observer/filing/0001217234-24-000062.json
- Plain text: https://secwatch.observer/filing/0001217234-24-000062.txt

## Key facts
- Earnings Releases
  CareDx, Inc. reported the first quarter ended March 31, 2024 results: revenue $72.0 million, net income net loss was $16.7 million, EPS $0.32. Guidance raised.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $72.0 million
  - Net income: net loss was $16.7 million
  - EPS: $0.32
  - Guidance: raised
  - Result: reported results
  source text: CareDx, Inc. (Nasdaq: CDNA) — today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights • Reported first quarter revenue of $72.0 million. • Revenue for Testing Services of $53.8 million, an increase of 15% as compared to the fourth quarter 2023. • Grew testing services patients results for the third consecutive
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/0001217234-24-000062-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.